ArticleJournal of immunotherapy (Hagerstown, Md. : 1997)2019

The VE-PTP Inhibitor AKB-9778 Improves Antitumor Activity and Diminishes the Toxicity of Interleukin 2 (IL-2) Administration.

Guanqiao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.